Navigation Links
Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook
Date:7/29/2009

ility of revenue mix between the Company's Brand, Generic and Distribution business units; periodic dependence on a small number of products for a material source of net revenue or income; variability of trade buying patterns; changes in generally accepted accounting principles; risks that the carrying values of assets may be negatively impacted by future events and circumstances; timely and successful consummation and implementation of strategic initiatives; the timing and success of product launches; the difficulty of predicting the timing or outcome of product development efforts and FDA or other regulatory agency approvals or actions; the uncertainty associated with the identification and successful consummation of external business development transactions; market acceptance of and continued demand for Watson's products; costs and efforts to defend or enforce intellectual property rights; difficulties or delays in manufacturing; the availability and pricing of third party sourced products and materials; successful compliance with FDA and other governmental regulations applicable to Watson's and its third party manufacturers' facilities, products and/or businesses; uncertainties related to the timing and outcome of litigation and other claims; changes in the laws and regulations, including Medicare and Medicaid, affecting among other things, pricing and reimbursement of pharmaceutical products; and such other risks and uncertainties detailed in Watson's periodic public filings with the Securities and Exchange Commission, including but not limited to Watson's Annual Report on Form 10-K for the year ended December 31, 2008. Except as expressly required by law, Watson disclaims any intent or obligation to update these forward-looking statements.

Adderall XR(R) is a registered trademark of Shire, LLC.

The following table presents Watson's results of operations for the three and six months ended June 30, 2009 and 200
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine news :

1. Watson Announces License Agreement With GeneraMedix for Generic Version of Ferrlecit(R)
2. Watson CFO Mark W. Durand to Take Leave of Absence
3. Watson Confirms Filing of Abbreviated New Drug Application for Generic Sanctura XR(R)
4. Watson Pharmaceuticals Receives a Complete Response Letter for Its 24-Week Formulation of TRELSTAR(R) (triptorelin pamoate) NDA from US FDA
5. Watson to Host Second Quarter 2009 Earnings Conference Call and Webcast
6. Watson Pharmaceuticals Resumes Shipment of INFeD(R) (Iron Dextran Injection, USP)
7. Watson Pharmaceuticals Receives FDA Approval for Fruit and Cinnamon Flavored Coated Nicotine Gums
8. Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B(R)
9. Watson to Acquire Arrow Group
10. Watson Files FDA Application for Generic Mucinex(R) D
11. Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... July 22, 2014 As reported on July ... caller request to name her favorite beauty products, “ Botox ... to say that “ Botox has changed my life” ... makeup chair preparing for her various, daily appearances. “Suddenly ... Ms. Ripa (see: goo.gl/shmTQM). , “I think that Kelly Ripa’s ...
(Date:7/22/2014)... Rochelle, NY -- New guidelines on cholesterol treatment and ... double the risk of dying from atherosclerotic cardiovascular disease ... do women with a similar risk profile (based on ... The implications of this finding for when and how ... Editorial in Journal of Men,s Health , a ...
(Date:7/22/2014)... Ticket Down is a reliable source for ... in Landover, MD. There has never been a better time ... After the success of the American national soccer team at the ... One way that fans of the world’s sport will be able ... Guinness International Champions Cup. The tournament will kick off on July ...
(Date:7/22/2014)... park is the heart of a community. That’s ... made a recent investment in outdoor recreation and fun ... equipment from American Parks Company™. , The community of ... a 475-unit community that was established in the 1970s. ... tropical paradise with lush shade trees, green-edged walking and ...
(Date:7/22/2014)... HealthDay Reporter TUESDAY, July 22, 2014 ... procedure known as morcellation carries a risk of spreading undetected ... clearly. Twenty-seven of every 10,000 women who had the ... procedure, researchers found, with the odds being highest for patients ... with morcellation use a power cutter to slice uterine tissue ...
Breaking Medicine News(10 mins):Health News:Celebrity Botox: Kelly Ripa Confesses to Getting Botox Injections 2Health News:Manchester United vs. Inter Milan Tickets Fedex Field Landover: Ticket Down Slashes Ticket Prices for Inter Milan ManU International Champions Cup Match in Washington, DC 2Health News:Manchester United vs. Inter Milan Tickets Fedex Field Landover: Ticket Down Slashes Ticket Prices for Inter Milan ManU International Champions Cup Match in Washington, DC 3Health News:Fun in the Florida Sun: Kendalltown Homeowners Association Inc. Expands Outdoor Recreation with American Parks Company™ 2Health News:Fun in the Florida Sun: Kendalltown Homeowners Association Inc. Expands Outdoor Recreation with American Parks Company™ 3Health News:Technique Used in Some Hysterectomies May Help Spread Cancer: Study 2Health News:Technique Used in Some Hysterectomies May Help Spread Cancer: Study 3
... , , WASHINGTON , Jan. ... will host its "2nd Annual World Congress Affordable Innovations ... conjunction  with the 7th Annual World Health Care Congress. ... can provide sustainable and scalable health solutions, often to ...
... New Birth Defect Research Reveals Craniofacial & ... CELEBRATION, Fla. , Jan. 19 Nearly two-thirds ... National Birth Defect Registry (NBDR) also suffer from structural birth ... (BDRC) . The group reported that most of the defects affect ...
... , ... Reliable, modern healthcare is Tri-Cities, Tennessee,s "ace ... improved quality of life. , With 9,000 and 6,900 employees respectively, ... Mountain States Health Alliance and Wellmont Health System ...
... inflammation, researchers note , TUESDAY, Jan. 19 (HealthDay News) ... for intensive care patients with the potentially lethal blood ... The study, published Jan. 19 in the journal ... oil in the normal IV nutrient solution given to ...
... Dobermans and hand-washing in humans could share similar DNA, ... -- A study of obsessive-compulsive Dobermans might someday help ... identified a region on chromosome 7 in obsessive-compulsive dogs ... psychiatric disorder. , The gene is the same ...
... ... Screening and Treatment , ... Heights, NJ (Vocus) January 19, 2010 -- During Glaucoma Awareness Month, Summit Medical Group wants ... the eyes that causes vision loss. Because there often are no symptoms in its early ...
Cached Medicine News:Health News:World Congress Announces Affordable Innovations in Health Exhibit and Awards 2010 at 7th Annual World Health Care Congress, Calls for Submissions from Organizations Striving to Improve Global Health Care 2Health News:World Congress Announces Affordable Innovations in Health Exhibit and Awards 2010 at 7th Annual World Health Care Congress, Calls for Submissions from Organizations Striving to Improve Global Health Care 3Health News:High Rates of Birth Defects Found in Autistic Children 2Health News:The Regional Alliance for Economic Development: Progressive Healthcare Helps Tri-Cities, Tennessee 2Health News:The Regional Alliance for Economic Development: Progressive Healthcare Helps Tri-Cities, Tennessee 3Health News:The Regional Alliance for Economic Development: Progressive Healthcare Helps Tri-Cities, Tennessee 4Health News:Adding Fish Oil to IV May Speed Sepsis Recovery 2Health News:Compulsive Dogs Yield Clues to Human OCD, Autism 2Health News:Compulsive Dogs Yield Clues to Human OCD, Autism 3Health News:January is Glaucoma Awareness Month 2
(Date:7/22/2014)... MARCOS, Texas , July 22, 2014 Quantum Materials ... and Mr. John Heaton to the Board of ... by Dr. Ghassan Jabbour , QMC Chief Science Officer and ... Michael Wong of Rice University and Mr. Tomio ... Japan . " Quantum Materials welcomes ...
(Date:7/21/2014)... McCord Research, Inc. was recently granted ... This patent describes a method for accelerating wound ... inventor, Dr. McCord, this method includes administering or ... composition of an effective amount of hydroxytyrosol and ... such that the administration of the combination reduces ...
(Date:7/21/2014)... July 21, 2014 Thoratec Corporation (NASDAQ: ... circulatory support therapies to save, support and restore failing ... results for the second quarter of fiscal year 2014 ... hold a conference call to discuss its financial results ... 1:30 p.m., Pacific Daylight Time (4:30 p.m., Eastern Daylight ...
Breaking Medicine Technology:Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 2Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 3Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 4US Patent Office Grants McCord Research Endothelial Cell Treatment Patent 2Thoratec Schedules Second Quarter Conference Call, Webcast 2
... April 23 Lixte,Biotechnology Holdings (OTC Bulletin Board: ... Zhengping Zhuang of the Surgical Neurology Branch (SNB),National ... of Health (NIH) and its collaborator, Lixte Biotechnology,Holdings. ... American Association,of Cancer Research that its lead compound ...
... Orthopedics, Inc.,announced today that it has successfully completed ... newest addition to the company,s product line,for treating ... in,the facet joints result in compression of spinal ... with moderate to,severe spinal stenosis undergo decompressive laminectomy ...
Cached Medicine Technology:Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research 2Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research 3First Human Implant of New Archus Orthopedics Facet Replacement System 2
... in corneal diagnostics. Precise Display of ... stroma, Bowman's membrane and epithelial layers. ... Applications in Surgery and Pathology. As ... endothelial cell analysis, haze detection, foreign ...
... is ideal for the physician who wishes ... broad base of clinical applications. The innovative ... in the treaent of deeper lying veins. ... for vascular and pigmented lesions, including IPL ...
The playful pattern of this lens features sky-blue forms fanning out from the center of your eye....
This design features a solid red iris....
Medicine Products: